Clinical Research Funding

Alan P. Sawchuk

Clinical Practice

Diagnostic Center

Section of Vascular Surgery

     Educational Programs
     Faculty
     Research Programs

To Contact

Search

Site Map

Welfide International Corporation, Catalyst Pharmaceutical Research LLC: "A Double-blind Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of Circulase for the Treatment of Critical Leg Ischemia". Principle Investigator, 2002-2003.

Welfide International Corporation, Catalyst Pharmaceutical Research LLC: "A Double-blind, Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of Circulase in Conjuction with Peripheral Revascularization for the Treatment of Critical Leg Ischemia". Principle Investigator, 2002-2004.

Alpha Therapeutic Corp: “A Double-Blind, Randomized, Parallel Group, Placebo-Controlled, Study to Evaluate the Safety and Efficacy of NM-702 in Subjects with Intermittent Claudication”. Principle Investigator, 1999-2001.

Schneider (USA), Inc.: “Wallgraft Endoprosthesis and the Unistep LS Delivery for Peripheral Aneurysms and Trauma”. Co-Invesitgator, 1998-2001.

Alpha Therapeutic Corp: “A Double-Blind, Randomized, Parallel Group, Placebo-Controlled, Study to Evaluate the Safety and Efficacy of Intravenous AS-013 in Lipid Emulsion in Subjects with Severe Limb Ischemia (Fontaine Stage IV)”. Principle Investigator, 03/02/98 - 12/31/2000.

Schneider (USA), Inc.: “Wallgraft Endoprosthesis and the Unistop LS Delivery System For Complex Iliac Stenosis and Occlusion. Co-Investigator, 1998-2000.

W.L. Gore & Associates: “A Randomized, Multicenter Study Comparing Use of the HEMOBAHN Endovascular Prosthesis to Percutaneous Transluminal Angioplasty (PTA) In the Treatment of Superficial Femoral Artery Obstructive Disease”. Co-Investigator, 1998-2000.

Park-Davis Pharmaceutical: “An Investigator-Blind, Randomized, Comparative Multicenter Study of Clinafloxacin Versus Piperacillin/Tazobactam in the Treatment of Complicated Skin and Soft Tissue Infections”. Principle Investigator, 1997-1998.

Magainin Pharmaceuticals, Inc.: “Study of the Comparative Efficacy of MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Foot Ulcers”. Principle Investigator, 1995-1996.

National Institutes of Health: “ASA and Carotid Endarterectomy (ACE): A Randomized Trial Of 4 Doses of ASA for the Prevention of Perioperative Stroke in Carotid Endarterectomy”. Co-Investigator, 1994-1998.

Otsuka American Pharmaceutical, Inc: “A Randomized, Double Blind, Placebo Controlled, Multidose Study of Cilostazol in Patients with Intermittent Claudication Secondary to Chronic Occlusive Disease”. Co-Investigator, 1993-1994.

Curative Technologies, Inc.: “CT-102 Activated Platelet Supernatant, Topical (APST)”. Principle Investigator, July 1, 1992-June 30, 1994.

National Institutes of Health Multicenter Study: “North American Symptomatic Carotid Endarterectomy Trial”. Co-Investigator, 1991-1998.

Abbott Laboratories Multicenter Study: “The Comparative Treatment of Deep Vein Thrombosis with Urokinase, Streptokinase and Heparin”. Co-Investigator, 1990-1997.

Medtronic, Inc. Multicenter Study: “A Study of Therapeutic Vascular Effects in Patients Receiving a Spinal Cord Stimulation System”. Co-Investigator, 1990-1993.

Berlex Laboratories Inc.: “Multicenter Placebo Controlled Study of Iloprost in Patients With Severe Atherosclerotic Peripheral Arterial Disease and Ischemic Ulcers (Fontaine Stage IV)”. Co-Investigator, 1990-1992.

Veterans AdministrationCooperative Study, #309: “The Role of Carotid Endarterectomy In Preventing Stroke from Symptomatic Carotid Stenosis”. Co-Investigator, 1990-1991.

URL: http://www.iuvascular.com/Research/Clinic/APSfundingc.html